| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.6M | -39.5% | -2.0% |
| R&D Expense | $18.3M | -0.4% | +5.5% |
| SG&A Expense | $7.1M | +7.1% | -11.0% |
| Operating Income | -$24.4M | +5.6% | +11.5% |
| Pre-tax Income | -$24.9M | +4.3% | -13.0% |
| Income Tax | $360K | +5900.0% | -4.3% |
| Net Income | -$25.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.3M | +80.2% | +24.5% |
| Short-term Investments | $203.9M | -0.4% | +116.9% |
| Current Assets | $262.2M | +9.4% | +87.4% |
| Total Assets | $416.1M | +4.6% | -11.6% |
| Current Liabilities | $16.6M | +34.0% | -18.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$55.0M | — | — |
| Capital Expenditures | $5.6M | — | — |
| Investing Cash Flow | $46.1M | — | — |
| Financing Cash Flow | $30.8M | — | — |
| Free Cash Flow | -$60.6M | — | — |
| -2.1% |
| -15.4% |
| EPS (Basic) | -$0.14 | +0.0% | -7.7% |
| EPS (Diluted) | -$0.14 | +0.0% | -7.7% |
| $34.6M |
| +27.3% |
| +10.2% |
| Stockholders' Equity | $381.2M | +2.9% | -13.3% |